Volume 7 Issue 1
Jan.  2016
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2016  >  7(1): 32-38
Li Fuxin, Li Chuan, Liu Tong, et al. Manufacture and comparison of chronic rejection model of orthotopic and heterotopic intestinal transplantation in rats[J]. ORGAN TRANSPLANTATION, 2016, 7(1): 32-38. doi: 10.3969/j.issn.1674-7445.2016.01.006
Citation: Li Fuxin, Li Chuan, Liu Tong, et al. Manufacture and comparison of chronic rejection model of orthotopic and heterotopic intestinal transplantation in rats[J]. ORGAN TRANSPLANTATION, 2016, 7(1): 32-38. doi: 10.3969/j.issn.1674-7445.2016.01.006
shu

Manufacture and comparison of chronic rejection model of orthotopic and heterotopic intestinal transplantation in rats

doi: 10.3969/j.issn.1674-7445.2016.01.006

  • Department of General Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China

More Information
  • Corresponding author: Liu Tong, E-mail:liutonga@126.com
  • Received Date: 2015-11-18
    Available Online: 2021-01-19
  • Publish Date: 2016-01-15
    Abstract
  •   Objective  To compare the modeling effect of chronic rejection following orthotopic and heterotopic intestinal transplantation in rats.  Methods  F344 (RT11vr) rats were used as the donors and Lewis (RT11) rats were used as the recipients. Models of allogeneic heterotopic and orthotopic intestinal transplantation in rats (8 rats in each model) were established, and subcutaneous injection of ciclosporin was given at 0~14 d after operation. Changes in body weight and survival time of the recipients were observed after operation. In addition, pathological changes in intestinal tissue were observed by hematoxylin-eosin (HE) staining. Changes in collagenous fibers and elastic fibers in intestinal tissue were observed after alcohol and hematoxylin staining. Finally, success rate of modeling of recipients in two groups was calculated.  Results  Rats in heterotopic and orthotopic intestinal transplantation groups were able to survive for a long time, most of which were more than 90 d. For the rats in orthotopic intestinal transplantation group, normal diet could be recovered at the 3rd d after operation. Their body weight could recover preoperative level at about the 14th d after operation, and then grew slowly. However, most of the rats in orthotopic intestinal transplantation group continued weight loss from the 150th d after operation, which could not be reversed with ciclosporin. For the rats in heterotopic intestinal transplantation group, normal diet could be recovered at the 1st d after operation, and their body weight could recover preoperative level within 25-30 d after operation and gradually rose and remained at a high level within 30-90 d after operation. No pathological changes of chronic rejection and obvious mesangial fibrosis in intestinal tissue were observed at the 90th d after operation, but intestinal tissue developed chronic rejection and obvious mesangial fibrosis at the 163rd d and 200th d after operation in orthotopic intestinal transplantation group. Typical pathological changes of chronic rejection and mesangial fibrosis in intestinal tissue were observed at the 90th d and 200th d after operation for rats in heterotopic intestinal transplantation group. All the rats in heterotopic intestinal transplantation group showed characteristic pathological changes. The success rate of modeling was 100% in heterotopic intestinal transplantation group, which was not of statistical significance, compared with the success rate of modeling of 75% in the orthotopic intestinal transplantation group(P > 0.05).  Conclusions  Chronic rejection will occur at different time points with small dose of ciclosporin after operation if models of orthotopic and heterotopic intestinal transplantation are established in combination of F344→Lewis rats. Compared with orthotopic intestinal transplantation, the rat model of heterotopic intestinal transplantation holds the advantages of simple modeling, shorter chronic rejection and relatively consistent degree of pathological changes, which is more suitable for experimental study.

     

    • FullText(HTML)
  • loading
    • References(17)
  • [1]
    Grant D, Abu-Elmagd K, Mazariegos G, et al. Intestinal transplant registry report: global activity and trends[J]. Am J Transplant, 2015, 15(1):210-219. doi: 10.1111/ajt.12979
    [2]
    Kubal CA, Mangus RS, Tector AJ. Intestine and multivisceral transplantation: current status and future directions[J]. Curr Gastroenterol Rep, 2015, 17(1):427. https://www.researchgate.net/publication/271334978_Intestine_and_Multivisceral_Transplantation_Current_Status_and_Future_Directions
    [3]
    Hilmi IA, Planinsic RM, Nicolau-Raducu R, et al. Isolated small bowel transplantation outcomes and the impact of immunosuppressants: experience of a single transplant center[J]. World J Transplant, 2013, 3(4):127-133. http://www.ncbi.nlm.nih.gov/pubmed/24392317
    [4]
    Abu-Elmagd KM, Costa G, Bond GJ, et al. Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges[J]. Ann Surg, 2009, 250(4):567-581. http://www.academia.edu/14388080/Five_hundred_intestinal_and_multivisceral_transplantations_at_a_single_center_Major_advances_with_new_challenges
    [5]
    Abu-Elmagd KM, Wu G, Costa G, et al. Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver[J]. Am J Transplant, 2012, 12(11):3047-3060. doi: 10.1111/j.1600-6143.2012.04237.x
    [6]
    Guo WH, Tian L, Dallmann MJ, et al. Comparative study of allograft survival of heterotopic and orthotopic small bowel transplantation in rat[J]. Transplantation, 2003, 75(11):1895-1897. doi: 10.1097/01.TP.0000065294.04793.11
    [7]
    Kitamura K, von Websky MW, Ohsawa I, et al. Orthotopic small bowel transplantation in rats[J]. J Vis Exp, 2012, (69): 4102.
    [8]
    Zhang W, Shen ZY, Song HL, et al. Protective effect of bone marrow mesenchymal stem cells in intestinal barrier permeability after heterotopic intestinal transplantation[J]. World J Gastroenterol, 2014, 20(23):7442-7451. doi: 10.3748/wjg.v20.i23.7442
    [9]
    Parizhskaya M, Redondo C, Demetris A, et al. Chronic rejection of small bowel grafts: pediatric and adult study of risk factors and morphologic progression[J]. Pediatr Dev Pathol, 2003, 6(3):240-250. doi: 10.1007/s10024-002-0039-4
    [10]
    Swanson BJ, Talmon GA, Wisecarver JW, et al. Histologic analysis of chronic rejection in small bowel transplantation: mucosal and vascular alterations[J]. Transplantation, 2013, 95(2):378-382. doi: 10.1097/TP.0b013e318270f370
    [11]
    Ruiz P. Updates on acute and chronic rejection in small bowel and multivisceral allografts[J]. Curr Opin Organ Transplant, 2014, 19(3):293-302. https://www.researchgate.net/publication/262148206_Updates_on_acute_and_chronic_rejection_in_small_bowel_and_multivisceral_allografts
    [12]
    Boluda ER. Pediatric small bowel transplantation[J]. Curr Opin Organ Transplant, 2015, 20(5):550-556. doi: 10.1097/MOT.0000000000000231
    [13]
    Pécora RA, David AI, Lee AD, et al. Small bowel transplantation[J]. Arq Bras Cir Dig, 2013, 26(3):223-229. doi: 10.1590/S0102-67202013000300013
    [14]
    Minneci PC. Intestinal transplantation: an overview[J]. Pathophysiology, 2014, 21(1):119-122. doi: 10.1016/j.pathophys.2013.11.014
    [15]
    Marco ML. The Fischer-Lewis model of chronic allograft rejection:a summary[J]. Nephrol Dial Transplant, 2006, 21(11):3082-3086. doi: 10.1093/ndt/gfl451
    [16]
    Shrestha B, Haylor J. Experimental rat models of chronic allograft nephropathy: a review[J]. Int J Nephrol Renovasc Dis, 2014, 7:315-322.
    [17]
    Li Y, Zhu Y, Wang J, et al. Long-term comparison of rat model of chronic allograft rejection of orthotopic small bowel transplantation induced by cyclosporine versus tacrolimus[J]. Transplant Proc, 2013, 45(5):1811-1815. doi: 10.1016/j.transproceed.2012.12.012
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (165) PDF downloads(15) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return